BRUSSELS (ANA/C. Vasilaki) - Amsterdam will be the new seat of the European Medicines Agency (EMA), after winning over Milan and Copenhagen in the second and third round of balloting in Brussels on Monday.
Milan and Amsterdam tied in the second vote and lots were drawn to determine the winner, according to diplomatic sources. Athens, which was a candidate city, gathered 10 votes, the same sources said and expressed satisfaction with the reception of the Greek proposal.
The selection took place in the margins of the General Affairs Council, in accordance with the procedure endorsed by the EU 27 heads of state and government on 22 June 2017.
The two EU agencies currently based in the UK, the EMA and the European Banking Authority (EBA), need to be relocated in the context of the Britain's withdrawal from the EU.
EMA is responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU and is essential for the functioning of the single market for medicines in the EU.